首页> 外文期刊>Epilepsy & behavior: E&B >Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model
【24h】

Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model

机译:癫痫液及锂纤维糖尿病模型及癫痫症后突触囊泡蛋白2A的差异表达

获取原文
获取原文并翻译 | 示例
       

摘要

Synaptic vesicle protein 2A (SV2A) has become an attractive target of investigation because of its role in the pathophysiology of epilepsy; SV2A is expressed ubiquitously throughout the brain in all nerve terminals independently of their neurotransmitter content and plays an important but poorly defined role in neurotransmission. Previous studies have shown that modifications in the SV2A protein expression could be a direct consequence of disease severity. Furthermore, these SV2A modifications may depend on specific changes in the nerve tissue following the induction of epilepsy and might be present in both excitatory and inhibitory terminals. Thus, we evaluated SV2A protein expression throughout the hippocampi of lithium-pilocarpine rats afterstatus epilepticus(SE) and during early and late epilepsy. In addition, we determined the γ-aminobutyric acid (GABA)ergic or glutamatergic nature associated with SV2A modifications. Wistar rats were treated with lithium-pilocarpine to induce SE and subsequently were shown to present spontaneous recurrent seizures (SRS). Later, we conducted an exhaustive semi-quantitative analysis of SV2A optical density (OD) throughout the hippocampus by immunohistochemistry. Levels of the SV2A protein were substantially increased in layers formed by principal neurons after SE, mainly because of GABAergic activity. No changes were observed in the early stage of epilepsy. In the late stage of epilepsy, there were minor changes in SV2A OD compared with the robust modifications of SE; however, SV2A protein expression generally showed an increment reaching significant differences in two dendritic layers and hilus, without clear modifications of GABAergic or glutamatergic systems. Our results suggest that the SV2A variations may depend on several factors, such as neuronal activity, and might appear in both excitatory and inhibitory systems depending on the epilepsy stage.
机译:突触囊泡蛋白2a​​(sv2a)已成为对癫痫病理生理学中的作用的有吸引力的调查目标;在所有神经终端中,SV2A在整个神经末端的整个脑中普遍表达,并且在神经递质含量中,在神经递质中起重要但不良定义的作用。以前的研究表明,SV2A蛋白表达中的修饰可能是疾病严重程度的直接后果。此外,这些SV2A修饰可以取决于癫痫诱导后神经组织的特定变化,并且可能存在于兴奋性和抑制终端中。因此,我们在锂 - 紫罗兰甘油大鼠AFTerstatus癫痫(SE)和早期和晚期癫痫期间,我们评估了整个海马的SV2A蛋白表达。此外,我们确定了与SV2A修饰相关的γ-氨基丁酸(GABA)ERGIC或谷氨酸酯性质。用锂 - 紫罗兰甘油处理Wistar大鼠以诱导SE,随后显示出现自发性复发性癫痫发作(Srs)。后来,我们通过免疫组织化学对整个海马的SV2A光密度(OD)进行了详尽的半定量分析。 SV2A蛋白的水平在SE之后的主要神经元形成的层中基本上增加,主要是因为加法力活性。癫痫早期没有观察到任何变化。在癫痫的晚期,与SE的稳健修改相比,SV2A OD的微小变化;然而,SV2A蛋白表达通常表现出增量达到两个树突层和HILUS的显着差异,而没有明确修饰Gabaergic或谷氨酸系统。我们的结果表明,SV2A变化可能取决于若干因素,例如神经元活动,并且可能在兴奋性和抑制系统中,这取决于癫痫阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号